These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30190512)

  • 1. The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm).
    Meng J; Zhang JG; Du ST; Li N
    Cancer Gene Ther; 2019 Mar; 26(3-4):114-117. PubMed ID: 30190512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma.
    Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N
    Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
    Donadon M; Terrone A; Procopio F; Cimino M; Palmisano A; Viganò L; Del Fabbro D; Di Tommaso L; Torzilli G
    Surgery; 2019 May; 165(5):897-904. PubMed ID: 30691871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental investigation of hepatic arterial embolism treatment with microsphere encapsulation of adenovirus with HSV-TK gene].
    Liu ZM; Li XX; Yan LN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):462-5. PubMed ID: 19627006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome.
    Zhang C; Feng S; Tu Z; Sun J; Rui T; Zhang X; Huang H; Ling Q; Zheng S
    Cancer Med; 2021 Sep; 10(18):6227-6238. PubMed ID: 34331411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of liver transplantation in patients with advanced hepatocellular carcinoma.
    Li N; Zhou J; Weng D; Zhang C; Li L; Wang B; Song Y; He Q; Lin D; Chen D; Chen G; Gao Q; Wang S; Xu G; Meng L; Lu Y; Ma D
    Clin Cancer Res; 2007 Oct; 13(19):5847-54. PubMed ID: 17908978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of prophylactic transarterial chemoembolization after radical resection of small hepatocellular carcinoma: A retrospective analysis.
    Fan S; Yu B; Wang X
    J Cancer Res Ther; 2017; 13(5):773-777. PubMed ID: 29237902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
    Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
    Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial.
    Wu X; Li B; Qiu J; Shen J; Zheng Y; Li Q; Liao Y; He W; Zou R; Yuan Y
    J Clin Gastroenterol; 2015 Jul; 49(6):520-8. PubMed ID: 25564411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
    Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
    World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T; Nakamoto Y; Sakai Y; Marukawa Y; Kitahara M; Mukaida N; Kaneko S
    J Immunol; 2007 Jan; 178(1):574-83. PubMed ID: 17182598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic hepatectomy for small hepatocellular carcinoma in Korea.
    Suh KS
    J Hepatobiliary Pancreat Surg; 2005; 12(5):365-70. PubMed ID: 16258804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.